J
Joseph Zohar
Researcher at Sheba Medical Center
Publications - 322
Citations - 13738
Joseph Zohar is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Major depressive disorder & Medicine. The author has an hindex of 58, co-authored 294 publications receiving 11430 citations. Previous affiliations of Joseph Zohar include Tel Aviv University.
Papers
More filters
Journal ArticleDOI
Suicide prevention strategies revisited: 10-year systematic review
Gil Zalsman,Gil Zalsman,Keith Hawton,Danuta Wasserman,Kees van Heeringen,Ella Arensman,Marco Sarchiapone,Vladimir Carli,Cyril Höschl,Ran Barzilay,Judit Balazs,György Purebl,Jean-Pierre Kahn,Pilar A. Saiz,Cendrine Bursztein Lipsicas,Julio Bobes,Doina Cozman,Ulrich Hegerl,Joseph Zohar +18 more
TL;DR: The evidence for restricting access to lethal means in prevention of suicide has strengthened since 2005, especially with regard to control of analgesics and hot-spots for suicide by jumping.
Journal ArticleDOI
Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance.
Orsolya Király,Marc N. Potenza,Dan J. Stein,Daniel L. King,David C. Hodgins,John B. Saunders,Mark D. Griffiths,Biljana Gjoneska,Joël Billieux,Matthias Brand,Max Abbott,Samuel R. Chamberlain,Ornella Corazza,Julius Burkauskas,Célia M. D. Sales,Christian Montag,Christine Lochner,Edna Grünblatt,Elisa Wegmann,Giovanni Martinotti,Hae Kook Lee,Hans-Jürgen Rumpf,Jesús Castro-Calvo,Afarin Rahimi-Movaghar,Susumu Higuchi,José M. Menchón,Joseph Zohar,Luca Pellegrini,Susanne Walitza,Naomi A. Fineberg,Zsolt Demetrovics +30 more
TL;DR: Although for the vast majority ICT use is adaptive and should not be pathologized, a subgroup of vulnerable individuals are at risk of developing problematic usage patterns and the present consensus guidance discusses these risks and makes some practical recommendations that may help diminish them.
Journal ArticleDOI
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.
Daniel Souery,Pierre Oswald,Isabelle Massat,Ursula F. Bailer,Joseph Bollen,Koen Demyttenaere,Siegfried Kasper,Yves Lecrubier,Stuart Montgomery,Alessandro Serretti,Joseph Zohar,Julien Mendlewicz +11 more
TL;DR: The findings provide a set of 11 relevant clinical variables associated with treatment resistance in major depressive disorder that can be explored at the clinical level and show that comorbid anxiety disorder is the most powerful clinical factor associated with TRD.
Journal ArticleDOI
Treatment resistant depression: methodological overview and operational criteria.
Daniel Souery,Jay D. Amsterdam,C de Montigny,Yves Lecrubier,Stuart Montgomery,Olivier Lipp,Giorgio Racagni,Joseph Zohar,Julien Mendlewicz +8 more
TL;DR: The proposed criteria are intended for therapeutic trials in TRD, combining the evaluation of treatment efficiency and the validation of the concept of TRD itself, including major depression with poor response to two adequate trials of different classes of antidepressants.
Journal ArticleDOI
Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology
Joseph Zohar,Thomas R. Insel +1 more
TL;DR: The results demonstrate that agents that bind to the 5HT-1 receptor can acutely affect the symptoms of OCD patients and suggest that serotonergic neurons may play a role in the pathophysiology, as well as mediating the pharmacological reduction, of obsessional symptoms.